Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)Business Wire • 03/21/24
Vertex Pharmaceuticals Incorporated (VRTX) Leerink Partners Global Biopharma Conference (Transcript)Seeking Alpha • 03/12/24
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.The Motley Fool • 03/09/24
Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 44th Annual Health Care Conference (Transcript)Seeking Alpha • 03/05/24
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X PotentialInvestorPlace • 03/04/24
Vertex Receives CHMP Positive Opinion for KALYDECO® for the Treatment of Infants With Cystic Fibrosis Ages 1 Month and OlderBusiness Wire • 02/23/24